Back
Biofrontera, Inc. 10K Form
Sell
23
BFRI
Biofrontera, Inc.
Last Price:
$0.73
Seasonality Move:
-41.3%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BFRI News And Ratings
See the #1 stock for the next 7 days that we like better than BFRI
BFRI Financial Statistics
Sales & Book Value
| Annual Sales: | $37.3M |
|---|---|
| Cash Flow: | $-3.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.22 |
| Price / Book: | 20.88 |
Profitability
| EPS (TTM): | -1.81720 |
|---|---|
| Net Income (TTM): | $-17.6M |
| Gross Margin: | $18.3M |
| Return on Equity: | -2760.29% |
| Return on Assets: | -94.72% |
Biofrontera, Inc. Earnings Forecast
Key Biofrontera, Inc. Financial Ratios
-
The Gross Profit Margin over the past 6 years for BFRI is 49.02%.
-
The Selling, General & Administrative Expenses for BFRI have been equal to 90.66% of Gross Profit Margin.
-
The Research & Development expenses have been 5.35% of Revenue.
-
The Net Earning history of BFRI is -47.58% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Biofrontera, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | BFRI |
| Website: | biofrontera-us.com |
Debt
| Debt-to-Equity Ratio: | -1.9 |
|---|---|
| Current Ratio: | 1.15 |
| Quick Ratio: | 0.52 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 26 |
BFRI Technical Analysis vs Fundamental Analysis
Sell
23
Biofrontera, Inc. (BFRI)
is a Sell
Is Biofrontera, Inc. a Buy or a Sell?
-
Biofrontera, Inc. stock is rated a SellThe current Biofrontera, Inc. [BFRI] share price is $0.72. The Score for BFRI is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.